By linking lab tests on detailed patient identifiers, a national, patient-level longitudinal cohort is being developed, which contains over 3 million ART initiators and over 23 million observations. This “NHLS Patient Cohort” will enable us to evaluate the national ART program using data that are nationally representative and robust to self-transfer across care settings. Through a partnership between Wits University in South Africa and Boston University in the U.S., this project will address each of the following specific aims, using the NHLS Patient Cohort:
- Quantify the effect of the national HIV testing campaign on uptake of HIV care and treatment
- Estimate national retention rates in pre-ART care and post-ART initiation
- Establish long run treatment outcomes for a national patient cohort
- Estimate the effects of immediate vs. deferred ART eligibility on retention and clinical outcomes
The following publications emanate from this project:
HE2RO staff involvedDr Mhairi Maskew William Macleod Cheryl Hendrickson Cornelius Nattey Lise Jamieson Ross Greener
Receive newsletters and keep up to date with developments at HE2RO.